Primary Record
nabumetone
- In stock
- 3,744 g
- Purity
- 99.8 %
- CAS
- 42924-53-8
Compound Identifiers & Properties
- CAS
- 42924-53-8
- PubChem CID
- 4409
- SMILES
- CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
- Canonical SMILES
- COc1ccc2cc(CCC(C)=O)ccc2c1
Names & Synonyms
- nabumetone
- Relafen
- Arthaxan
- Nabumetona
- Relifen
- Relifex
- 42924-53-8
- Listran
- nabumeton
- Consolan
- Mebutan
- Balmox
- Relif
- Nabumetonum
- Unimetone
- Dolsinal
- Flambate
- Prodac
- 4-(6-methoxynaphthalen-2-yl)butan-2-one
- Nabuser
- Nabucox
- ApoNabumetone
- nabuton
- Nabumetone-d3
- Arthraxan
- Rhoxal nabumetone
- gamma-Mangostin
- Apo-Nabumetone
- Gen-Nabumetone
- Nabumetone RS
- 4-(6-Methoxy-2-naphthyl)-2-butanone
- Nabumetone CRS
- Rhoxal-nabumetone
- Nabumetonum [INN-Latin]
- Nabumetone (oral)
- Nabumatone Form II
- Relafen (TN)
- Nabumetone 500 mg
- Nabumetone 750 mg
- BRL-14777
- Nabumetone (Standard)
- RELAFEN DS
- Nabumetone 1000 mg
- LW0TIW155Z
- Spectrum_001486
- NABUMETONE [MI]
- Opera_ID_765
- RefChem:55684
- UNII-LW0TIW155Z
- DTXSID4045472
- NABUMETONE [INN]
- NABUMETONE [JAN]
- Prestwick0_000909
- Prestwick1_000909
- Prestwick2_000909
- Prestwick3_000909
- Spectrum2_001969
- Spectrum4_000174
- Spectrum5_001286
- NABUMETONE [USAN]
- 4-(2-Methoxynaphthalen-6-yl)butan-2-one
- 4-(6-Methoxy-2-naphthalenyl)-2-butanone
- MLS000069541
- 6-MNA (oral), Nobex
- Nabumetone (oral), Nobex
- BRL 14777
- NABUMETONE [VANDF]
- D05CKR
- C15H16O2
- AC1L1I3P
- AC1Q4F4K
- cid_4409
- NABUMETONE [MART.]
- SCHEMBL2256
- BLXXJMDCKKHMKV-UHFFFAOYSA-N
- CCRIS 8108
- CHEBI:7443
- CHEMBL1070
- NABUMETONE [USP-RS]
- NABUMETONE [WHO-DD]
- MFCD00079518
- BSPBio_000758
- DTXCID2025472
- KBioGR_000687
- KBioSS_001966
- BRL14777
- MLS001076325
- BIDD:GT0104
- DivK1c_000850
- NSC-758623
- SPECTRUM1503650
- SPBio_002097
- SPBio_002957
- 2-Butanone, 4-(6-methoxy-2-naphthalenyl)-
- Nabumetone, analytical standard
- BPBio1_000834
- GTPL7245
- Nabumetone (JP17/USP/INN)
- Nabumetone - Bio-X trade mark
- Nabumetone [USAN:BAN:INN:JAN]
- orb1309207
- orb3025300
- NABUMETONE [ORANGE BOOK]
- SCHEMBL18096515
- SCHEMBL29373228
- SCHEMBL29570823
- BDBM40128
- CTK8B4843
- ERK5-3G19
- HMS502K12
- HY-B0559R
- KBio1_000850
- KBio2_001966
- KBio2_004534
- KBio2_007102
- ZINC20221
- BRN 2103472
- CID4409
- M01AX01
- MSK7165
- NABUMETONE [EP MONOGRAPH]
- NABUMETONE [USP IMPURITY]
- NNB-001
- NNB-004
- NNB-005
- NINDS_000850
- HMS1570F20
- HMS1922G10
- HMS2090D13
- HMS2093I05
- HMS2097F20
- HMS2230H12
- HMS3259I16
- HMS3652M04
- HMS3714F20
- HMS3885A22
- HMS5082E04
- NABUMETONE [USP MONOGRAPH]
- Pharmakon1600-01503650
- SMR000058835
- Nabumetone [USAN:INN:BAN:JAN]
- 4-(6-methoxy-2-naphthyl)butan-2-one
- BCP12152
- CID:4409
- HY-B0559
- Nabumetone [USAN:USP:INN:BAN:JAN]
- Nabumetone EPCRS (N0020000)
- Tox21_110647
- ANW-46490
- CCG-39507
- EBC-26251
- NCGC00016853-01
- NSC758623
- s4051
- 2-(3-Oxobutyl)-6-methoxynaphthalene
- AKOS009529199
- MSK7165-1000A
- Tox21_110647_1
- 4-[6-methoxy-2-naphthyl]-2-butanone
- C15-H16-O2
- CS-2669
- DB00461
- FN26115
- KS-1371
- Nabumetone (USAN:USP:INN:BAN:JAN)
- NC00579
- NSC 758623
- 1-(6-Methoxy-2-naphthyl)-3-butanone
- CAS-42924-53-8
- IDI1_000850
- 4-(6-methoxy-2-naphthyl)-butan-2-one
- NCGC00016853-02
- NCGC00016853-03
- NCGC00016853-06
- NCGC00016853-13
- NCGC00095063-01
- NCGC00095063-02
- AC-19025
- AJ-08410
- AK-86115
- BN166181
- CPD000058835
- J16.442I
- LS-46825
- M727
- SAM002564225
- SC-77045
- ZB000767
- 1-(2'-Methoxynaphth-6'-yl)butan-3-one
- 2-butanona, 4-(6-metoxi-2-naftalenil)-
- SBI-0051869.P002
- SID:376229626
- ST2405403
- TC-135235
- AB00052392
- AM20040460
- B1450
- FT-0629765
- FT-0672583
- NS00003590
- SW197312-3
- D00425
- L10109
- 4-[6-(trideuteriomethoxy)naphthalen-2-yl]butan-2-one
- AB00052392-13
- AB00052392_14
- AB00052392_15
- EN300-1853581
- Nabumetone Solution in Acetonitrile, 1000ug/mL
- 924N538
- A826072
- C035605
- F211337
- Q425207
- SR-01000759138
- SR-01000759138-2
- SR-01000759138-3
- BRD-K65146499-001-04-8
- BRD-K65146499-001-14-7
- BRD-K65146499-001-26-1
- BRD-K65146499-001-27-9
- D000077430
- Nabumetone, British Pharmacopoeia (BP) Reference Standard
- Nabumetone, European Pharmacopoeia (EP) Reference Standard
- Nabumetone, United States Pharmacopeia (USP) Reference Standard
- Nabumetone; (Relafen; 4-(6-methoxy-2-naphthyl)-2-butanone)
- 1216770-08-9
- 641-917-1
- Nabumetone; 4-(6-Methoxy-2-naphthalenyl)-2-butanone; 1-(2'-Methoxynaphth-6'-yl)butan-3-one; 4-(6-Methoxy-2-naphthyl)-2-butanone; Arthaxan; BRL 14777; Balmox; Consolan; Nabumeton; Nabumetone; Nabuser; Relafen; Relifen; Relifex; BRL-14777
- NbO